孕前空腹及餐后胰岛素水平与复发性流产患者早产风险的阈值效应分析
收稿日期: 2025-01-25
修回日期: 2025-05-12
录用日期: 2025-08-05
网络出版日期: 2025-12-24
基金资助
上海市科委自然科学基金(23ZR1450100)
Threshold Analysis of Pre-pregnancy Fasting and Postprandial Insulin Levels on the Risk of Preterm Birth in Patients with Recurrent Abortion
Received date: 2025-01-25
Revised date: 2025-05-12
Accepted date: 2025-08-05
Online published: 2025-12-24
目的:探究孕前胰岛素水平(INS)与复发性流产(RSA)患者早产风险的相关性。方法:采用回顾性列队研究设计,依据妊娠结局将2020年1月至2021年12月期间在本院成功妊娠且活产的594例RSA患者分为足月产组和早产组。测定患者孕前空腹、餐后30 min、1 h、2 h、3 h的INS0、INS05、INS1、INS2、INS3,分析INS水平与早产的相关性。结果:594例RSA活产患者早产率8.25%。单因素回归分析显示,孕前血清INS0、INS2水平与早产显著相关(P<0.05)。阈值效应分析显示,孕前INS0=8.41 U·mL-1和INS2=61.18 U·mL-1均是区分RSA孕妇足月分娩和早产的拐点(P<0.05);多因素Logistic回归分析显示,RSA患者孕前INS0≥8.41 U·mL-1(aOR=2.25,95%CI:1.09, 4.63)、INS2≥61.18 U·mL-1(aOR=2.31,95% CI:1.16, 4.60)均是影响其早产的独立危险因素(P<0.05)。Logistic回归分析显示,RSA孕前INS0是影响妊娠期高血压和脐带畸形的危险因素,孕前INS2水平是影响孕妇妊娠期糖尿病、羊水量异常、脐带畸形的危险因素(P<0.05)。结论:RSA患者再次妊娠前INS0≥8.41 U·mL-1、INS2≥61.18 U·mL-1是影响早产发生的独立危险因素,同时孕前INS0高分泌会增加妊娠期高血压和脐带畸形发生风险,INS2高分泌会增加患者妊娠期糖尿病、羊水量异常、脐带畸形发生风险,建议将孕前INS0和INS2筛查纳入RSA患者早产风险评估体系。
丁秋红
,
鲍时华
,
邓胥晶
,
曲荣贵
.
孕前空腹及餐后胰岛素水平与复发性流产患者早产风险的阈值效应分析
Objective: To investigate the correlation between pre-pregnancy insulin (INS) levels and the risk of preterm birth in patients with recurrent abortion (RSA).Methods: A retrospective cohort study design was used to divide 594 RSA patients with successful pregnancy and live birth in our hospital from January 2020 to December 2021 into term birth group and premature birth group according to pregnancy outcomes. INS0, INS05, INS1, INS2 and INS3 levels were measured before pregnancy on fasting, 30 min, 1 h, 2 h and 3 h after meal. The correlation between INS level and preterm birth was analyzed.Results: The preterm birth rate of the 594 RSA patients was 8.25%. Univariate regression analysis showed that serum INS0 and INS2 levels before pregnancy were significantly correlated with preterm delivery (P<0.05). Threshold effect analysis showed that pre-pregnancy INS0=8.41 U·mL-1 and INS2=61.18 U·mL-1 were the inflection points to distinguish full-term delivery and preterm delivery of RSA pregnant women (P<0.05). Multivariate Logistic regression analysis showed that INS0≥8.41 U·mL-1 (aOR=2.25, 95%CI: 1.09, 4.63) and INS2≥61.18 U·mL-1 (aOR=2.31, 95%CI: 1.16, 4.60) were independent risk factors for preterm birth (P<0.05). Logistic regression analysis showed that RSA pre-pregnancy INS0 was a risk factor for gestational hypertension and umbilical cord malformation, while pre-pregnancy INS2 level was a risk factor for gestational diabetes, amniotic fluid volume abnormality and umbilical cord malformation (P<0.05).Conclusion: INS0≥8.41 U·mL-1 and INS2≥61.18 U·mL-1 before pregnancy are independent risk factors for preterm delivery in RSA patients. Meanwhile, high INS0 secretion before pregnancy may increase the risk of pregnancy hypertension and umbilical cord malformation. High INS2 secretion can increase the risk of gestational diabetes mellitus, abnormal amniotic fluid volume, and abnormal umbilical cord. It is suggested that preconception INS0 and INS2 screening should be included in the risk assessment system of preterm delivery in RSA patients.
[1] 自然流产诊治中国专家共识编写组.自然流产诊治中国专家共识(2020年版)[J]. 中国实用妇科与产科杂志,2020,36(11):1082-1090.
[2] Green DM, O'Donoghue K. A review of reproductive outcomes of women with two consecutive miscarriages and no living child[J].J Obstet Gynaecol, 2019,39(6):816-821.
[3] Walani SR. Global burden of preterm birth[J].Int J Gynaecol Obstet, 2020,150(1):31-33.
[4] Zhang Y, Feng M, Gao Y, et al. Depression outcome in women with recurrent spontaneous abortion: a systematic review and meta-analysis[J].Eur J Obstet Gynecol Reprod Biol, 2024,300(1):54-62.
[5] Aktemur G, Tokgöz Çakır B, Sucu S, et al. Does corpus luteum doppler have a role in prognostic prediction for outcome with threatened abortion[J].J Clin Med, 2025,14(5):1419-1431.
[6] Wang Q, Bai W, Li C, et al. Effect of low dose prednisone on glucose metabolism levels in patients with spontaneous abortion: A single-center, prospective cohort study[J].J Reprod Immunol, 2024,166(1):104395-104415.
[7] Hantoushzadeh S, Kohandel Gargari O, Shafiee A, et al. Glucose metabolism tests and recurrent pregnancy loss: evidence from a systematic review and meta-analysis[J].Diabetol Metab Syndr, 2023,15(1):3-11.
[8] 胡倩,张哲慧,王博雅,等.复发性流产患者体质指数、胰岛素水平与糖代谢状态的特征研究[J].安徽医科大学学报,2021,56(11):1798-1802.
[9] Liu S, Chen Y, Zhang A, et al. Association of spontaneous abortion and lifestyle with diabetes mellitus in women: a cross-sectional study in UK Biobank[J].BMC Pregnancy Childbirth, 2025,25(1):362-371.
[10] Al Balawi AN, Alblwi NAN, Soliman R, et al. Impact of vitamin D deficiency on immunological and metabolic responses in women with recurrent pregnancy loss: focus on VDBP/HLA-G1/CTLA-4/ENTPD1/adenosine-fetal-maternal conflict crosstalk[J].BMC Pregnancy Childbirth, 2024,24(1):709-727.
[11] Goto S, Ozaki Y, Ozawa F, et al. Impaired decidualization and relative increase of PROK1 expression in the decidua of patients with unexplained recurrent pregnancy loss showing insulin resistance[J].J Reprod Immunol, 2023, 160(1):104155-104168.
[12] Zamir I, Stoltz Sjöström E, van den Berg J, et al. Insulin resistance prior to term age in very low birthweight infants: a prospective study[J].BMJ Paediatr Open, 2024,8(1):e002470-e002479.
[13] Korpysz A, Wysocka-Mincewicz M, Szalecki M. Assessment of insulin resistance in preterm children appropriate for gestational age versus term and preterm children with intrauterine growth restriction[J].Pediatr Endocrinol Diabetes Metab, 2021,7(4):249-252.
[14] Yıldız Z, Kayğın MA, Özkara T, et al. Effects of deep venous thrombosis treatments on early and long-term quality of life: medical therapy vs. systemic thrombolysis vs. pharmacomechanical thrombolysis[J].Vasc Endovascular Surg, 2024,58(1):5-12.
[15] Jia D, Sun F, Han S, et al. Adverse outcomes in subsequent pregnancies in women with history of recurrent spontaneous abortion: a meta-analysis[J].J Obstet Gynaecol Res, 2024,50(3):281-297.
[16] 张婧文,崔金全,王娜.复发性流产女性再次妊娠产科结局分析[J].现代妇产科进展,2024,33(5):340-344,351.
[17] Mourou L, Vallone V, Vania E, et al. Assessment of the effect of pregnancy planning in women with type 1 diabetes treated by insulin pump[J].Acta Diabetol, 2021,58(3):355-362.
[18] 李惠卿,陈辉雄,张万霖,等.早产孕妇血小板参数、纤维蛋白原及D-二聚体水平的变化[J]. 国际检验医学杂志,2014,35(6):667-668,670.
[19] Ekin A, Gezer C, Kulhan G, et al. Can platelet count and mean platelet volume during the first trimester of pregnancy predict preterm premature rupture of membranes[J].J Obstet Gynaecol Res, 2015,41(1):23-28.
[20] Ma M, Zhu M, Zhuo B, et al. Use of complete blood count for predicting preterm birth in asymptomatic pregnant women: a propensity score-matched analysis[J].J Clin Lab Anal, 2020,34(8):e23313-e23320.
[21] 李艳,邓洋,郝明鱼,等.复发性流产与代谢性指标相关性研究[J].生殖医学杂志,2023,32(1):38-42.
[22] 陈艺璇,吴琳琳,吴晓霞,等.妊娠早期心血管代谢风险与不良妊娠结局的深圳出生队列研究[J].中华心血管病杂志,2024,52(2):158-164.
[23] 谭洁,霍亮亮.妊娠期糖尿病患者早期空腹血糖异常对妊娠结局的影响[J].中国妇幼保健,2024,39(9):1558-1562.
[24] 李穗湘.胰岛素抵抗与早产的相关性研究[J].中华全科医学,2012,10(7):1017,1026-1027.
[25] 朱进璐,季俊男,严立祥.妊娠期糖尿病产妇胎盘中NF-κB和GLUT4表达量对胰岛素抵抗的相关性分析[J].中国妇幼保健,2024,39(17):3289-3292.
[26] Pioch A, Markwitz W, Litwin A, et al.Inteleukin-6 secretion during pathophysiological events of pregnancy-preterm birth, preeclampsia, fetal growth restriction, gestational diabetes mellitus[J].J Med Sci, 2024,93(2):141-152.
[27] 王百苗,叶平,熊智慧,等.复发性流产患者血清维生素D水平与胰岛素抵抗的相关性分析[J].中国现代医生,2020,58(2):59-62,66.
[28] He FF, Li YM. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review[J].J Ovarian Res, 2020,13(1):73-81.
/
| 〈 |
|
〉 |